Detalhe da pesquisa
1.
Bacteria-to-Human Protein Networks Reveal Origins of Endogenous DNA Damage.
Cell
; 176(1-2): 127-143.e24, 2019 01 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30633903
2.
Dual Chromatin and Cytoskeletal Remodeling by SETD2.
Cell
; 166(4): 950-962, 2016 Aug 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27518565
3.
Epichaperome inhibition targets TP53-mutant AML and AML stem/progenitor cells.
Blood
; 142(12): 1056-1070, 2023 09 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37339579
4.
Chemically targeting the redox switch in AP1 transcription factor ΔFOSB.
Nucleic Acids Res
; 50(16): 9548-9567, 2022 09 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36039764
5.
EphA2- and HDAC-Targeted Combination Therapy in Endometrial Cancer.
Int J Mol Sci
; 25(2)2024 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38279277
6.
Evolution of cisplatin resistance through coordinated metabolic reprogramming of the cellular reductive state.
Br J Cancer
; 128(11): 2013-2024, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37012319
7.
Combination of EphA2- and Wee1-Targeted Therapies in Endometrial Cancer.
Int J Mol Sci
; 24(4)2023 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36835335
8.
Bexarotene - a novel modulator of AURKA and the primary cilium in VHL-deficient cells.
J Cell Sci
; 131(24)2018 12 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-30518623
9.
PanCancer insights from The Cancer Genome Atlas: the pathologist's perspective.
J Pathol
; 244(5): 512-524, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29288495
10.
Vincristine Enhances the Efficacy of MEK Inhibitors in Preclinical Models of KRAS-mutant Colorectal Cancer.
Mol Cancer Ther
; 22(8): 962-975, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37310170
11.
Molecular pathways enhance drug response prediction using transfer learning from cell lines to tumors and patient-derived xenografts.
Sci Rep
; 12(1): 16109, 2022 09 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36168036
12.
deepOrganoid: A brightfield cell viability model for screening matrix-embedded organoids.
SLAS Discov
; 27(3): 175-184, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35314378
13.
Combined TRIP13 and Aurora Kinase Inhibition Induces Apoptosis in Human Papillomavirus-Driven Cancers.
Clin Cancer Res
; 28(20): 4479-4493, 2022 10 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35972731
14.
Screening of GPCR drugs for repurposing in breast cancer.
Front Pharmacol
; 13: 1049640, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36561339
15.
Endocrine disrupting chemicals differentially alter intranuclear dynamics and transcriptional activation of estrogen receptor-α.
iScience
; 24(11): 103227, 2021 Nov 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-34712924
16.
Morphological screening of mesenchymal mammary tumor organoids to identify drugs that reverse epithelial-mesenchymal transition.
Nat Commun
; 12(1): 4262, 2021 07 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34253738
17.
Therapeutically actionable signaling node to rescue AURKA driven loss of primary cilia in VHL-deficient cells.
Sci Rep
; 11(1): 10461, 2021 05 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34002003
18.
A High-throughput Approach to Identify Effective Systemic Agents for the Treatment of Anaplastic Thyroid Carcinoma.
J Clin Endocrinol Metab
; 106(10): 2962-2978, 2021 09 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34120183
19.
Rational Combination of CRM1 Inhibitor Selinexor and Olaparib Shows Synergy in Ovarian Cancer Cell Lines and Mouse Models.
Mol Cancer Ther
; 20(12): 2352-2361, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34583979
20.
Mammary-specific expression of Trim24 establishes a mouse model of human metaplastic breast cancer.
Nat Commun
; 12(1): 5389, 2021 09 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34508101